Phong Phu Pharmaceutical JSC (HNX:PPP)

Market Cap	190.96B
Revenue (ttm)	141.69B
Net Income (ttm)	17.46B
Shares Out	8.80M
EPS (ttm)	1,988.41
PE Ratio	10.91
Forward PE	n/a
Dividend	1,500.00 (6.91%)
Ex-Dividend Date	Mar 21, 2025

Volume	200
Average Volume	1,135
Open	21,500
Previous Close	20,000
Day's Range	21,400 - 21,500
52-Week Range	15,700 - 22,100
Beta	0.04
RSI	58.38
Earnings Date	Jul 21, 2025

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals. The ...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 212
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PPP

Financial Performance

In 2024, HNX:PPP's revenue was 137.55 billion, a decrease of -9.61% compared to the previous year's 152.17 billion. Earnings were 15.55 billion, a decrease of -14.28%.